Defunct Company
Total Trials
11
As Lead Sponsor
9
As Collaborator
2
Total Enrollment
913
NCT01208194
Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 30, 2010
Completion: Mar 31, 2013
NCT01265368
A Clinical Study to Assess Safety and Efficacy of a Tumor Vaccine in Patients With Advanced Renal Cell Carcinoma (ASET)
Phase: Phase 1/2
Start: Nov 30, 2010
Completion: Sep 30, 2018
NCT01283711
Evaluation of Safety and Efficacy of the Apollo™ System for Treatment of Wrinkles and Rhytides
Phase: N/A
Start: Mar 31, 2011
Completion: Sep 30, 2011
NCT01566396
Evaluation of Safety and Efficacy of the 3F Applicator (A3F) for Treatment of Facial Wrinkles
Start: Mar 31, 2012
Completion: Oct 31, 2012
NCT01858415
Evaluation of Safety and Efficacy of TriPollar Device for Treatment of Wrinkles
Start: Apr 30, 2013
Completion: Not specified
NCT01982747
A Phase I Study to Assess Cardiac and General Safety and Pharmacokinetics of 60 mg MGN1703
Phase: Phase 1
Start: Nov 30, 2013
Completion: Dec 31, 2013
NCT02200081
Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC
Start: Mar 31, 2014
Completion: Oct 5, 2017
NCT02077868
Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction Treatment
Phase: Phase 3
Start: Sep 30, 2014
Completion: May 31, 2020
NCT02668770
Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies
Role: Collaborator
Start: May 11, 2016
Completion: Dec 31, 2025
NCT04357821
Combinatorial Therapy to Induce an HIV Remission
Start: Aug 1, 2020
NCT06315166
Study on Using Radiofrequency to Treat Moderate to Severe Acne
Start: May 23, 2024